Skip to content
November 5, 2026 india
Follow Us:
  • Facebook
  • X / Twitter
  • Instagram
  • YouTube
  • LinkedIn
Navjeevan Express

Navjeevan Express

Voice of the common man

  • Home
  • National
  • Politics
  • Business
    • automobiles
    • Aviation
    • Banking
    • Budget
    • Capital Market
  • World
  • Sports
  • Tech
  • Lifestyle
    • Health & Environment
    • Awards
    • Travel
    • Youth
    • Book Review
    • Food
    • Festivals
  • Entertainment
    • Bollywood
    • Film Review
    • Cinema
    • Dhollywood
ILUMYA (tildrakizumab-asmn) approved in the US for the treatment of adults with active psoriatic arthritis
America / Breaking News / Business / Health & Environment / Hospitals / Maharashtra / Mumbai / National / New York / Pharma

ILUMYA (tildrakizumab-asmn) approved in the US for the treatment of adults with active psoriatic arthritis

October 30, 2026

US FDA approves ILUMYA for adults with active psoriatic arthritis Approval expands the drug’s use beyond moderate-to-severe plaque […]

Copyright © 2026. All rights reserved. Theme Rubik News by Kantipur Themes